{"transactions":[{"id":2195811,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:39:49.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001209191-22-044287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122044287/doc4.xml","form_type":"4"}},{"id":2247611,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":1250,"derivative":{"exercise_price":5.8098,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2247610,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2247609,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":500,"price":55.25,"value":27625.0,"ownership":{"direct":true},"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2247608,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":313,"price":55.4352,"value":17351.2176,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2247607,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":313,"price":5.8098,"value":1818.4674,"ownership":{"direct":true},"balance_after":4313,"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2247606,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":313,"price":55.32,"value":17315.16,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2247605,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:02:25.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":313,"price":3.925,"value":1228.525,"ownership":{"direct":true},"balance_after":4313,"source":{"system":"sec-edgar","filing":"0001209191-22-033477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122033477/doc4.xml","form_type":"4"}},{"id":2261861,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:02:35.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-22-030954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122030954/doc4.xml","form_type":"4"}},{"id":2354525,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":2813,"derivative":{"exercise_price":15.82,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354524,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":1563,"derivative":{"exercise_price":5.8098,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354523,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":313,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354522,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":625,"price":61.2681,"value":38292.5625,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354521,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":625,"price":15.82,"value":9887.5,"ownership":{"direct":true},"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354520,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":625,"price":61.402,"value":38376.25,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354519,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":625,"price":5.8098,"value":3631.125,"ownership":{"direct":true},"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354518,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":625,"price":61.4202,"value":38387.625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2354517,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-03T22:01:08.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":625,"price":3.925,"value":2453.125,"ownership":{"direct":true},"balance_after":2625,"source":{"system":"sec-edgar","filing":"0001209191-22-015590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122015590/doc4.xml","form_type":"4"}},{"id":2583599,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":3438,"derivative":{"exercise_price":15.82,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583598,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":2188,"derivative":{"exercise_price":5.8098,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583597,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":938,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583596,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":312,"price":91.442,"value":28529.904,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583595,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":312,"price":5.8098,"value":1812.6576,"ownership":{"direct":true},"balance_after":2312,"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583594,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":312,"price":91.054,"value":28408.848,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583593,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":312,"price":15.82,"value":4935.84,"ownership":{"direct":true},"balance_after":2312,"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583592,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":312,"price":91.3806,"value":28510.7472,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2583591,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T21:50:06.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":312,"price":3.925,"value":1224.6,"ownership":{"direct":true},"balance_after":2312,"source":{"system":"sec-edgar","filing":"0001209191-21-054292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121054292/doc4.xml","form_type":"4"}},{"id":2679380,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T21:25:50.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":125,"price":74.17,"value":9271.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $74.09 to $74.29, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-038717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121038717/doc4.xml","form_type":"4"}},{"id":2683316,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares\nvesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":3750,"derivative":{"exercise_price":15.82,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2683315,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares\nvesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":2500,"derivative":{"exercise_price":5.81,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2683314,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":1250,"derivative":{"exercise_price":3.93,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2683313,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":1876,"price":71.4102,"value":133965.5352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $71.2781 to $71.4784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2125,"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2683312,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":1250,"price":15.82,"value":19775.0,"ownership":{"direct":true},"balance_after":4001,"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2683311,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":313,"price":5.81,"value":1818.53,"ownership":{"direct":true},"balance_after":2751,"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2683310,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:41:06.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":313,"price":3.93,"value":1230.09,"ownership":{"direct":true},"balance_after":2438,"source":{"system":"sec-edgar","filing":"0001209191-21-037821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121037821/doc4.xml","form_type":"4"}},{"id":2699012,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:25:23.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units relating to 2,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 20, 2021, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":2125,"source":{"system":"sec-edgar","filing":"0001209191-21-035449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121035449/doc4.xml","form_type":"4"}},{"id":2794718,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-03-11T22:19:01.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":2187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":2813,"derivative":{"exercise_price":5.8098,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":2187},"source":{"system":"sec-edgar","filing":"0001209191-21-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121019850/doc4.xml","form_type":"4"}},{"id":2794717,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-03-11T22:19:01.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":1563,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-21-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121019850/doc4.xml","form_type":"4"}},{"id":2794716,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T22:19:01.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":3374,"price":101.6248,"value":342882.0752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $100.5077 to $103.6447, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":125,"source":{"system":"sec-edgar","filing":"0001209191-21-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121019850/doc4.xml","form_type":"4"}},{"id":2794715,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T22:19:01.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":2187,"price":5.8098,"value":12706.0326,"ownership":{"direct":true},"balance_after":3499,"source":{"system":"sec-edgar","filing":"0001209191-21-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121019850/doc4.xml","form_type":"4"}},{"id":2794714,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T22:19:01.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":937,"price":3.925,"value":3677.725,"ownership":{"direct":true},"balance_after":1312,"source":{"system":"sec-edgar","filing":"0001209191-21-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919121019850/doc4.xml","form_type":"4"}},{"id":2975280,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-19T00:48:57.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after April 13, 2016, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2026-04-12","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001209191-20-059268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120059268/doc4.xml","form_type":"4"}},{"id":2975279,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T00:48:57.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":4269,"price":44.2438,"value":188876.7822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $44.16 to $44.3784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":375,"source":{"system":"sec-edgar","filing":"0001209191-20-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120059268/doc4.xml","form_type":"4"}},{"id":2975278,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T00:48:57.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":2631,"price":0.38,"value":999.78,"ownership":{"direct":true},"balance_after":4644,"source":{"system":"sec-edgar","filing":"0001209191-20-059268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120059268/doc4.xml","form_type":"4"}},{"id":3052451,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-20T01:09:15.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The units subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after June 22, 2016, and 1/16th of such units vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":12.312,"expiration_date":"2026-06-21","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001209191-20-047657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120047657/doc4.xml","form_type":"4"}},{"id":3052450,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T01:09:15.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":3914,"price":40.8705,"value":159967.137,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $40.72 to $41.03, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":2013,"source":{"system":"sec-edgar","filing":"0001209191-20-047657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120047657/doc4.xml","form_type":"4"}},{"id":3052449,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T01:09:15.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":2631,"price":12.312,"value":32392.872,"ownership":{"direct":true},"balance_after":5927,"source":{"system":"sec-edgar","filing":"0001209191-20-047657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120047657/doc4.xml","form_type":"4"}},{"id":3133825,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-27T23:48:07.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares  vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":15.82,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-032439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032439/doc4.xml","form_type":"4"}},{"id":3133824,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-27T23:48:07.000Z","date":"2020-05-22","kind":"exercise","acquired":false,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after February 23, 2016, and 1/16th of such shares  vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001209191-20-032439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032439/doc4.xml","form_type":"4"}},{"id":3133823,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-27T23:48:07.000Z","date":"2020-05-22","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares  vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":2500,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-032439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032439/doc4.xml","form_type":"4"}},{"id":3133822,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T23:48:07.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":8677,"price":15.3611,"value":133288.2647,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $15.29 to $15.48, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":3296,"source":{"system":"sec-edgar","filing":"0001209191-20-032439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032439/doc4.xml","form_type":"4"}},{"id":3133821,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T23:48:07.000Z","date":"2020-05-22","kind":"exercise","acquired":true,"shares":2631,"price":0.38,"value":999.78,"ownership":{"direct":true},"balance_after":11973,"source":{"system":"sec-edgar","filing":"0001209191-20-032439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032439/doc4.xml","form_type":"4"}},{"id":3133820,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T23:48:07.000Z","date":"2020-05-22","kind":"exercise","acquired":true,"shares":2500,"price":3.925,"value":9812.5,"ownership":{"direct":true},"balance_after":9342,"source":{"system":"sec-edgar","filing":"0001209191-20-032439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919120032439/doc4.xml","form_type":"4"}},{"id":3504763,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T20:06:29.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares  vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":5.8098,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-033853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919119033853/doc4.xml","form_type":"4"}},{"id":3924097,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T20:04:46.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":3.925,"expiration_date":"2028-05-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-031800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919118031800/doc4.xml","form_type":"4"}},{"id":4285704,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T00:23:27.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 2,000 restricted stock units (\"RSUs\") granted to Mr. Bolger in connection with his reelection as a director of the Issuer. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest over a period of four years, with 1/4th of the shares subject to the RSUs vesting 12 months after May 16, 2017, and 1/16th of the remaining shares subject to the RSUs vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed because the name of the reporting person was incorrect in the Form 4 as originally filed. This line item is being re-reported in this amendment in order to gain access to the filing system for purposes of filing this amendment."}],"balance_after":6842,"source":{"system":"sec-edgar","filing":"0001209191-17-039311","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919117039311/doc4a.xml","form_type":"4/A","original_submission_date":"2017-05-18"}},{"id":4572969,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T20:15:38.000Z","date":"2016-10-26","kind":"grant","acquired":true,"shares":4842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 4,842 restricted stock units (\"RSUs\") granted to Mr. Bolger in connection with his appointment as a director of the Issuer. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest over a period of four years, with 1/4th of the shares subject to the RSUs vesting 12 months after September 28, 2016, and 1/16th of the remaining shares subject to the RSUs vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date."}],"balance_after":4842,"source":{"system":"sec-edgar","filing":"0001209191-16-147290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116147290/doc4.xml","form_type":"4"}},{"id":4587148,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Issuer Stock Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":2631,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The securities were received in the Reorganization in exchange for the cancellation of options to purchase 20,000 of the Predecessor's Class D non-voting common units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after June 22, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."}],"balance_after":2631,"derivative":{"exercise_price":12.312,"expiration_date":"2026-06-21","underlying":"Issuer Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587147,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Issuer Stock Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":2631,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The securities were received in the Reorganization in exchange for the cancellation of options to purchase 20,000 of the Predecessor's Class D non-voting common units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after April 13, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."}],"balance_after":2631,"derivative":{"exercise_price":0.38,"expiration_date":"2026-04-12","underlying":"Issuer Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587146,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Issuer Stock Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":2631,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The securities were received in the Reorganization in exchange for the cancellation of options to purchase 20,000 of the Predecessor's Class D non-voting common units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after February 23, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."}],"balance_after":2631,"derivative":{"exercise_price":0.38,"expiration_date":"2026-02-22","underlying":"Issuer Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587145,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Predecessor Unit Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-09-30","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The securities were disposed of and cancelled in the Reorganization in exchange for options to purchase 2,631 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after June 22, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."}],"balance_after":0,"derivative":{"exercise_price":1.62,"expiration_date":"2026-06-21","underlying":"Predecessor Class D Non-Voting Common Units","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587144,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Predecessor Unit Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-09-30","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The securities were disposed of and cancelled in the Reorganization in exchange for options to purchase 2,631 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after April 13, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."}],"balance_after":0,"derivative":{"exercise_price":0.05,"expiration_date":"2026-04-12","underlying":"Predecessor Class D Non-Voting Common Units","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587143,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Predecessor Unit Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-09-30","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The securities were disposed of and cancelled in the Reorganization in exchange for options to purchase 2,631 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after February 23, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."}],"balance_after":0,"derivative":{"exercise_price":0.05,"expiration_date":"2026-02-22","underlying":"Predecessor Class D Non-Voting Common Units","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587142,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Predecessor Unit Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-06-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after June 22, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."}],"balance_after":20000,"derivative":{"exercise_price":1.62,"expiration_date":"2026-06-21","underlying":"Predecessor Class D Non-Voting Common Units","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}},{"id":4587141,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":124940,"kind":"person","name":"BOLGER JOHN C","position":1,"cik":"0001183863","reported_name":"BOLGER JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Predecessor Unit Option (Right to Buy)","published_at":"2016-10-04T22:14:43.000Z","date":"2016-04-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares or units, as applicable, subject to the option vest over a period of four years, with 1/4th of such shares or units, as applicable, vesting 12 months after April 13, 2016, and 1/16th of the remaining shares or units, as applicable, vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Bolger's continued service for the Predecessor or the Issuer on each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Reflects securities of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\"). Fulgent LLC is considered the predecessor of Fulgent Genetics, Inc. (the \"Issuer\") following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the initial public offering of the Issuer and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all options to purchase the Predecessor's Class D non-voting common units were cancelled in exchange for options to purchase shares of the Issuer's common stock at a ratio of 7.6-for-1."}],"balance_after":20000,"derivative":{"exercise_price":0.05,"expiration_date":"2026-04-12","underlying":"Predecessor Class D Non-Voting Common Units","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-144660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919116144660/doc4.xml","form_type":"4"}}]}